Literature DB >> 3283035

Antimicrobial prophylaxis in neutropenic patients after bone marrow transplantation.

T Schmeiser1, E Kurrle, R Arnold, D Krieger, W Heit, H Heimpel.   

Abstract

Fourty-one patients with haematological malignancies or severe aplastic anaemia underwent allogeneic or syngeneic bone marrow transplantation and received one of two forms of infection prophylaxis while granulocytopenic: total decontamination in strict reverse isolation (ITD, 26 patients) or selective decontamination of the digestive tract with barrier nursing (SD, 15 patients). The patients were evaluated for infection acquisition, fever days, days on systemic antibiotics and granulocyte transfusions from 48 hours after the beginning of the decontamination procedure until 1,000 granulocytes/microliter have been reached. Ten of 26 patients of the ITD group remained free of febrile episodes and infections, whereas all patients of the SD group acquired infections (p less than 0.001). During granulocytopenia patients of the ITD group had fewer fever days, were less frequently on systemic antibiotics and received fewer granulocyte transfusions as compared with the SD group. Both methods were obviously very effective in preventing gram-negative infections, infections caused by Staphylococcus aureus and infections due to yeasts or fungi. No death due to infection occurred in either group. However, the data of this study provide evidence that ITD is a more effective antimicrobial prophylaxis in bone marrow transplant recipients than SD.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3283035     DOI: 10.1007/bf01646924

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  22 in total

Review 1.  Infection in bone marrow transplant recipients.

Authors:  J D Meyers
Journal:  Am J Med       Date:  1986-07-28       Impact factor: 4.965

Review 2.  Prevention of infection in neutropenic bone marrow transplant patients.

Authors:  T R Rogers
Journal:  Antibiot Chemother (1971)       Date:  1985

3.  Colonization pattern of the digestive tract by potentially pathogenic microorganisms: colonization-controlling mechanisms and consequences for antibiotic treatment.

Authors:  D van der Waaij
Journal:  Infection       Date:  1983       Impact factor: 3.553

Review 4.  Infections in bone marrow transplant recipients.

Authors:  J W van der Meer; H F Guiot; P J van den Broek; R van Furth
Journal:  Semin Hematol       Date:  1984-04       Impact factor: 3.851

5.  Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.

Authors:  D T Sleijfer; N H Mulder; H G de Vries-Hospers; V Fidler; H O Nieweg; D van der Waaij; H K van Saene
Journal:  Eur J Cancer       Date:  1980-06       Impact factor: 9.162

6.  Protected environment - prophylactic antibiotic program for malignant sarcomas: randomized trial during remission induction chemotherapy.

Authors:  G P Bodey; V Rodriguez; W K Murphy; A Burgess; R S Benjamin
Journal:  Cancer       Date:  1981-05-15       Impact factor: 6.860

7.  Protective environment for marrow transplant recipients: a prospective study.

Authors:  C D Buckner; R A Clift; J E Sanders; J D Meyers; G W Counts; V T Farewell; E D Thomas
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

8.  Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: effects of prophylactic measures.

Authors:  C D Buckner; R A Clift; E D Thomas; J Hersman; J E Sanders; P S Stewart; J C Wade; M Murphy; G Counts; J D Meyers
Journal:  Infection       Date:  1983 Sep-Oct       Impact factor: 3.553

9.  Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study.

Authors:  H F Guiot; P J van den Broek; J W van der Meer; R van Furth
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

10.  Prediction by surveillance cultures of bacteremia among neutropenic patients treated in a protective environment.

Authors:  M L Cohen; M T Murphy; G W Counts; C D Buckner; R A Clift; J D Meyers
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

View more
  4 in total

1.  Clinical use of selective decontamination: the concept.

Authors:  D van der Waaij; W L Manson; J P Arends; H G de Vries-Hospers
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Infectious complications after allogeneic bone marrow transplantation with and without T-cell depletion of donor marrow.

Authors:  T Schmeiser; M Wiesneth; D Bunjes; R Arnold; B Hertenstein; W Heit; E Kurrle
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

Review 3.  The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.

Authors:  Tessa M Andermann; Jonathan U Peled; Christine Ho; Pavan Reddy; Marcie Riches; Rainer Storb; Takanori Teshima; Marcel R M van den Brink; Amin Alousi; Sophia Balderman; Patrizia Chiusolo; William B Clark; Ernst Holler; Alan Howard; Leslie S Kean; Andrew Y Koh; Philip L McCarthy; John M McCarty; Mohamad Mohty; Ryotaro Nakamura; Katy Rezvani; Brahm H Segal; Bronwen E Shaw; Elizabeth J Shpall; Anthony D Sung; Daniela Weber; Jennifer Whangbo; John R Wingard; William A Wood; Miguel-Angel Perales; Robert R Jenq; Ami S Bhatt
Journal:  Biol Blood Marrow Transplant       Date:  2018-02-19       Impact factor: 5.742

Review 4.  Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD.

Authors:  Natalie Köhler; Robert Zeiser
Journal:  Front Immunol       Date:  2019-01-17       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.